EA015237B1 - Способ осуществления реакций обмена лития - Google Patents
Способ осуществления реакций обмена лития Download PDFInfo
- Publication number
- EA015237B1 EA015237B1 EA200901037A EA200901037A EA015237B1 EA 015237 B1 EA015237 B1 EA 015237B1 EA 200901037 A EA200901037 A EA 200901037A EA 200901037 A EA200901037 A EA 200901037A EA 015237 B1 EA015237 B1 EA 015237B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- reaction
- lithium
- group
- lithium exchange
- alkyl
- Prior art date
Links
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 96
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical group [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 title claims abstract description 46
- 229910052744 lithium Inorganic materials 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 23
- 239000012530 fluid Substances 0.000 claims abstract description 39
- 239000003153 chemical reaction reagent Substances 0.000 claims description 45
- 150000001875 compounds Chemical class 0.000 claims description 28
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 125000003118 aryl group Chemical group 0.000 claims description 16
- -1 1 0 C 3- cycloalkyl Chemical group 0.000 claims description 14
- 125000003545 alkoxy group Chemical group 0.000 claims description 11
- 125000001072 heteroaryl group Chemical group 0.000 claims description 11
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 8
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000000304 alkynyl group Chemical group 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 4
- 125000004986 diarylamino group Chemical group 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 3
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 claims description 3
- 239000000376 reactant Substances 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 abstract description 5
- 239000007924 injection Substances 0.000 abstract description 5
- 239000006227 byproduct Substances 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 125000003282 alkyl amino group Chemical group 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000002900 organolithium compounds Chemical class 0.000 description 3
- 238000013021 overheating Methods 0.000 description 3
- 239000012070 reactive reagent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- CETVQRFGPOGIQJ-UHFFFAOYSA-N lithium;hexane Chemical compound [Li+].CCCCC[CH2-] CETVQRFGPOGIQJ-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000012048 reactive intermediate Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- QMYGFTJCQFEDST-UHFFFAOYSA-N 3-methoxybutyl acetate Chemical group COC(C)CCOC(C)=O QMYGFTJCQFEDST-UHFFFAOYSA-N 0.000 description 1
- UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 description 1
- RHPVVNRNAHRJOQ-UHFFFAOYSA-N 4-methyl-n-(4-methylphenyl)aniline Chemical group C1=CC(C)=CC=C1NC1=CC=C(C)C=C1 RHPVVNRNAHRJOQ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 150000000475 acetylene derivatives Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001502 aryl halides Chemical class 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical group NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- 125000005266 diarylamine group Chemical group 0.000 description 1
- 125000005240 diheteroarylamino group Chemical group 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 150000002642 lithium compounds Chemical class 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- ANYSGBYRTLOUPO-UHFFFAOYSA-N lithium tetramethylpiperidide Chemical compound [Li]N1C(C)(C)CCCC1(C)C ANYSGBYRTLOUPO-UHFFFAOYSA-N 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- HMMPCBAWTWYFLR-UHFFFAOYSA-N n-pyridin-2-ylpyridin-2-amine Chemical compound C=1C=CC=NC=1NC1=CC=CC=N1 HMMPCBAWTWYFLR-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical group [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/02—Lithium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
- C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07002522A EP1956023A1 (en) | 2007-02-06 | 2007-02-06 | Method for lithium exchange reactions |
| PCT/EP2008/000808 WO2008095646A1 (en) | 2007-02-06 | 2008-02-01 | Method for lithium exchange reactions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200901037A1 EA200901037A1 (ru) | 2010-02-26 |
| EA015237B1 true EA015237B1 (ru) | 2011-06-30 |
Family
ID=38179681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200901037A EA015237B1 (ru) | 2007-02-06 | 2008-02-01 | Способ осуществления реакций обмена лития |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8198487B2 (enExample) |
| EP (2) | EP1956023A1 (enExample) |
| JP (1) | JP5394258B2 (enExample) |
| CN (1) | CN101605800B (enExample) |
| AT (1) | ATE478877T1 (enExample) |
| BR (1) | BRPI0807155A2 (enExample) |
| CA (1) | CA2674560A1 (enExample) |
| DE (1) | DE602008002321D1 (enExample) |
| EA (1) | EA015237B1 (enExample) |
| ES (1) | ES2351376T3 (enExample) |
| HR (1) | HRP20100627T1 (enExample) |
| IL (1) | IL199749A (enExample) |
| MX (1) | MX2009008352A (enExample) |
| PL (1) | PL2109616T3 (enExample) |
| PT (1) | PT2109616E (enExample) |
| SI (1) | SI2109616T1 (enExample) |
| WO (1) | WO2008095646A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2010002695A (es) | 2007-09-10 | 2010-04-01 | Janssen Pharmaceutica Nv | Proceso para la preparacion de compuestos utiles como inhibidores de transportador de glucosa dependiente de sodio (sglt). |
| US9056850B2 (en) | 2008-10-17 | 2015-06-16 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of SGLT |
| US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
| JP5658751B2 (ja) | 2009-07-10 | 2015-01-28 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプＪａｎｓｓｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｎａａｍｌｏｚｅ Ｖｅｎｎｏｏｔｓｃｈａｐ | １−（β−Ｄ−グルコピラノシル）−４−メチル−３−［５−（４−フルオロフェニル）−２−チエニルメチル］ベンゼンのための結晶化方法 |
| WO2011047113A1 (en) * | 2009-10-14 | 2011-04-21 | Janssen Pharmaceutica Nv | Process for the preparation of compounds useful as inhibitors of sglt2 |
| NZ703128A (en) | 2010-05-11 | 2016-04-29 | Janssen Pharmaceutica Nv | Pharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt |
| WO2012140120A1 (en) | 2011-04-13 | 2012-10-18 | Janssen Pharmaceutica Nv | Process for the preparation of compounds useful as inhibitors of sglt2 |
| TWI542596B (zh) | 2011-05-09 | 2016-07-21 | 健生藥品公司 | （２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體 |
| US20170071970A1 (en) | 2015-09-15 | 2017-03-16 | Janssen Pharmaceutica Nv | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders |
| HUE059090T2 (hu) * | 2017-11-14 | 2022-10-28 | Albemarle Germany Gmbh | Szerves lítium eljárás folyamatos áramlási körülmények között |
| DE102019008481A1 (de) | 2018-12-21 | 2020-06-25 | Merck Patent Gmbh | Kontinuierliches Verfahren zur Funktionalisierung von fluorierten Benzolverbindungen im Strömungsrohr |
| CN110510637B (zh) * | 2019-08-22 | 2021-02-23 | 山东师范大学 | 一种锂循环合成氨的系统及工艺 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1500649A1 (de) * | 2003-07-22 | 2005-01-26 | CPC Cellular Process Chemistry Systems GmbH | Verfahren zur Durchführung einer In-Situ-Quench Reaktion |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19858856A1 (de) * | 1998-12-19 | 2000-06-21 | Merck Patent Gmbh | Verfahren zur Herstellung von Arylmetallverbindungen und deren Umsetzung mit Elektrophilen |
| DE10028754A1 (de) * | 2000-06-09 | 2001-12-13 | Clariant Gmbh | Verfahren zur Herstellung von alkoholischen Lösungen von Alkalialkoholaten |
| JP4639042B2 (ja) * | 2003-09-29 | 2011-02-23 | 富士フイルムファインケミカルズ株式会社 | ハロゲン−リチウム交換反応を用いる有機化合物の製造法 |
| JP4794873B2 (ja) * | 2005-03-03 | 2011-10-19 | 富士フイルムファインケミカルズ株式会社 | ハロゲン−リチウム交換反応を用いる有機化合物の製造法 |
| AT501927B1 (de) * | 2005-05-23 | 2007-06-15 | Dsm Fine Chem Austria Gmbh | Verbessertes verfahren zur durchführung von ritterreaktionen, elektrophilen additionen an alkenen oder friedel-crafts-alkylierungen |
| WO2008035633A1 (en) * | 2006-09-19 | 2008-03-27 | Banyu Pharmaceutical Co., Ltd. | Reaction apparatus, and reaction method |
-
2007
- 2007-02-06 EP EP07002522A patent/EP1956023A1/en not_active Withdrawn
-
2008
- 2008-02-01 AT AT08707494T patent/ATE478877T1/de active
- 2008-02-01 BR BRPI0807155-1A2A patent/BRPI0807155A2/pt not_active IP Right Cessation
- 2008-02-01 HR HR20100627T patent/HRP20100627T1/hr unknown
- 2008-02-01 PT PT08707494T patent/PT2109616E/pt unknown
- 2008-02-01 US US12/524,910 patent/US8198487B2/en active Active
- 2008-02-01 CN CN200880004269XA patent/CN101605800B/zh not_active Expired - Fee Related
- 2008-02-01 DE DE602008002321T patent/DE602008002321D1/de active Active
- 2008-02-01 CA CA002674560A patent/CA2674560A1/en not_active Abandoned
- 2008-02-01 EP EP08707494A patent/EP2109616B1/en not_active Not-in-force
- 2008-02-01 WO PCT/EP2008/000808 patent/WO2008095646A1/en not_active Ceased
- 2008-02-01 MX MX2009008352A patent/MX2009008352A/es active IP Right Grant
- 2008-02-01 SI SI200830092T patent/SI2109616T1/sl unknown
- 2008-02-01 EA EA200901037A patent/EA015237B1/ru not_active IP Right Cessation
- 2008-02-01 JP JP2009548607A patent/JP5394258B2/ja not_active Expired - Fee Related
- 2008-02-01 ES ES08707494T patent/ES2351376T3/es active Active
- 2008-02-01 PL PL08707494T patent/PL2109616T3/pl unknown
-
2009
- 2009-07-07 IL IL199749A patent/IL199749A/en not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1500649A1 (de) * | 2003-07-22 | 2005-01-26 | CPC Cellular Process Chemistry Systems GmbH | Verfahren zur Durchführung einer In-Situ-Quench Reaktion |
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0807155A2 (pt) | 2014-04-22 |
| CN101605800A (zh) | 2009-12-16 |
| JP2010518035A (ja) | 2010-05-27 |
| JP5394258B2 (ja) | 2014-01-22 |
| US8198487B2 (en) | 2012-06-12 |
| HK1138008A1 (en) | 2010-08-13 |
| EP2109616A1 (en) | 2009-10-21 |
| IL199749A (en) | 2013-02-28 |
| ATE478877T1 (de) | 2010-09-15 |
| EP1956023A1 (en) | 2008-08-13 |
| MX2009008352A (es) | 2009-10-30 |
| IL199749A0 (en) | 2010-04-15 |
| CN101605800B (zh) | 2013-01-09 |
| DE602008002321D1 (de) | 2010-10-07 |
| SI2109616T1 (sl) | 2010-12-31 |
| EP2109616B1 (en) | 2010-08-25 |
| EA200901037A1 (ru) | 2010-02-26 |
| PT2109616E (pt) | 2010-11-29 |
| US20100113839A1 (en) | 2010-05-06 |
| WO2008095646A1 (en) | 2008-08-14 |
| HRP20100627T1 (hr) | 2010-12-31 |
| ES2351376T3 (es) | 2011-02-03 |
| PL2109616T3 (pl) | 2011-05-31 |
| CA2674560A1 (en) | 2008-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101605800B (zh) | 锂交换反应方法 | |
| Dolbier Jr et al. | A new zinc difluorocarbenoid reagent | |
| IL268432A (en) | Carboxylation reaction in continuous flow | |
| CN110922330B (zh) | 一种丙烯酸羟乙酯的制备方法 | |
| TW201934565A (zh) | 用於製備含磷的α-胺基腈之方法 | |
| CN108212044A (zh) | 金属-溴代芳烃的连续置换反应设备、连续置换方法及二者的应用 | |
| KR20220101115A (ko) | 하이드록삼산의 합성을 위한 연속 유동 프로세스 | |
| CN101495488B (zh) | 在微反应器中的格里纳德型反应 | |
| CN102796030A (zh) | 由甲硫醇和丙烯醛液液反应制备3-甲硫基丙醛的方法及装置 | |
| JP4861835B2 (ja) | イミドエーテル化合物の製造方法 | |
| CN113861027A (zh) | 一种连续流合成氯甲酸酯类化合物的方法 | |
| JP4471078B2 (ja) | アルキルベンズアルデヒド類の製造方法 | |
| JPH03232535A (ja) | パラジウムに基づく新規触媒及びその使用 | |
| Hafner et al. | Continuous Manufacturing as an Enabling Technology for Low‐Temperature Organometallic Chemistry | |
| CN101613364B (zh) | 七甲基二硅氮烷的制备方法 | |
| CN119409551B (zh) | 一种间三联苯类化合物的连续化合成方法及装置 | |
| Yan et al. | The efficient synthesis of Pregabalin with impurity control using a continuous flow system | |
| CN115340503B (zh) | 一种手性半咕啉化合物的合成方法及应用 | |
| CN119371274A (zh) | 一种1,2-双取代芳烃化合物的连续化合成方法及装置 | |
| KR20200122121A (ko) | 연속 흐름 공정을 이용한 cis-다이아미노 에논계 화합물의 제조 방법 | |
| RU2128639C1 (ru) | Способ получения аллилхлорида | |
| HK1138008B (zh) | 锂交换反应方法 | |
| AU2024230864A1 (en) | Flow chemistry process for preparing aza-bicyclic heteroaryl compounds | |
| CN106673978A (zh) | 3,5‑二氯‑2‑戊酮的连续化合成方法 | |
| CN114956989A (zh) | 一种异丁酰氯的连续合成方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KG MD TJ TM |
|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): KZ RU |